CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
Study Number | Lead Group | Study Title | CIRB | Study Status |
---|---|---|---|---|
A191402CD | Alliance | Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men | Cancer Prevention and Control CIRB | Completed |
A222001 | Alliance | A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Men Receiving Androgen Deprivation Therapy | Cancer Prevention and Control CIRB | Available to Open |
URCC-22053 | NCORP-University of Rochester Cancer Center | High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients | Cancer Prevention and Control CIRB | Available to Open |
MDA2016-08-02 | CP-CTNet_CLO-MD Anderson | A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer | Cancer Prevention and Control CIRB | Completed |
NRG-CC003 | NRG | Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with Or without Hippocampal Avoidance for Small Cell Lung Cancer | Cancer Prevention and Control CIRB | Available to Open |
A171901 | Alliance | Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist's/Patient's Choice) | Cancer Prevention and Control CIRB | Available to Open |
UAZ2015-05-01 | CP-CTNet_CLO-University of Arizona | A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys | Cancer Prevention and Control CIRB | Available to Open |
MAY2016-07-01 | CP-CTNet_CLO-Mayo Clinic | Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis | Cancer Prevention and Control CIRB | Completed |
UAZ21-07-01 | CP-CTNet_CLO-University of Arizona | M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention | Cancer Prevention and Control CIRB | Available to Open |
MAY2016-07-01F | CP-CTNet_CLO-Mayo Clinic | Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Weekly Erlotinib for Familial Adenomatous Polyposis | Cancer Prevention and Control CIRB | Completed |